Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
125 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Unknown  Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)
Condition: Tinea Pedis
Intervention: Drug: Topical therapy
22 Recruiting Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
Conditions: Invasive Pulmonary Aspergillosis;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: caspofungin
23 Recruiting Pilot Study to Evaluate Plasma Treatment of Onychomycosis
Condition: Onychomycosis
Intervention: Device: MOE Antimicrobial Plasma Treatment System
24 Unknown  Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord
Conditions: Infection;   Skin Diseases, Bacterial;   Granuloma
Interventions: Behavioral: Hygiene;   Procedure: Usual alcohol care
25 Recruiting Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: Miltefosine
26 Recruiting Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis
Condition: Onychomycosis of Toenails
Intervention: Device: PinPointe  Foot Laser
27 Unknown  Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
Condition: Reccurent Herpes Labialis
Interventions: Drug: Acyclovir 5%;   Drug: Docosanol 10%;   Device: Superlysine  gel
28 Unknown  Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
Condition: Onychomycosis
Intervention: Device: Laser Treatment (Pulsed Nd:YAG 1064 nm Laser)
29 Unknown  Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Intervention:
30 Unknown  Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
31 Recruiting A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail
Condition: Onychomycosis
Interventions: Drug: VT-1161;   Drug: Placebo
32 Unknown  Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Conditions: Papillomavirus Infections;   Warts;   Condylomata Acuminata;   Epidermodysplasia Verruciformis
Interventions: Other: PURELL VF481;   Other: Placebo Comparator
33 Recruiting Cytokines and Chemokines in Erythema Migrans
Condition: Erythema Migrans
Intervention: Drug: antibiotic treatment
34 Recruiting Pharmacokinetics of Miltefosine in Children and Adults
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
35 Unknown  Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis
Condition: Onychomycosis
Interventions: Drug: Amorolfine (Antifungal);   Drug: RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
36 Unknown  Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
37 Not yet recruiting Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
Condition: Blastomycosis
Interventions: Drug: amphotericin-B;   Drug: voriconazole
38 Recruiting Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis;   A. Fumigatus
Intervention: Dietary Supplement: cholecalciferol (Vitamin D3)
39 Recruiting A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Inhaled budesonide;   Drug: Inhaled amphotericin
40 Recruiting Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing
Conditions: Invasive Aspergillosis;   Pleural Effusion;   Immunosuppression
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years